sar443579
sanofi
['hr-mds', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'mds']
congress| #asco23| anthony stein, reported preliminary results from the first in-human trial evaluating sar443579 in pts with r/r aml, b-all or hr-mds. overall, it was well tolerated with no dlts; cr/cri was achieved in 18.8% at a dose of 1000 ug/kg/infusion
#allsm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm